Literature DB >> 24981070

The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study.

I M Miller1, C Ellervik, K Zarchi, K S Ibler, G R Vinding, K M Knudsen, G B Jemec.   

Abstract

BACKGROUND: Psoriasis (PS) has been suggested to be associated with the metabolic syndrome (MetS) in numerous studies with conflicting results. The vast majority of previous data were based on PS subjects from hospitals, and when based on data from the general population the PS subjects were often identified in insurance health databases. Furthermore, many studies used a single method approach, e.g. self-reported diagnosis.
OBJECTIVE: We have therefore investigated a possible association between PS and MetS on PS subjects from the hospital as well as the general population using combined methods, i.e. self-reported diagnosis, physical examinations and blood samples.
METHODS: A population- and hospital-based cross-sectional study of the possible association between PS and MetS.
RESULTS: Thirty-six hospital PS subjects, 860 population PS subjects and 14,016 non-PS subjects were identified. The odds ratios (ORs) for hospital PS subjects and population PS subjects vs. population non-PS subjects, respectively, were 5.14 (2.47-10.69) and 1.29 (1.09-1.53) for MetS, 4.55 (1.91-10.85) and 1.16 (0.85-1.59) for diabetes, 1.92 (0.87-4.22) and 1.00 (0.86-1.17) for hypertension, 4.34 (1.86-10.10) and 1.15 (1.00-1.34) for hypertriglyceridaemia, 3.88 (1.96-7.69) and 1.19 (1.01-1.42) for hypoHDL, 5.77 (2.89-11.52) and 1.19 (1.00-1.41) for general obesity and 2.92 (1.45-5.88) and 1.34 (1.16-1.55) for abdominal obesity. Obesity acted as a possible confounder. A uniform pattern of higher ORs for hospital PS subjects when compared to population PS subjects was observed. The severity and duration of PS did not seem to affect the results. As this is a cross-sectional study we cannot demonstrate causality.
CONCLUSION: The data suggested an association between PS and MetS as well as its individual parameters on a hospital-based level, with the exception of hypertension. On a population-based level the associations were only significant for MetS, hypoHDL and abdominal obesity.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2014        PMID: 24981070     DOI: 10.1111/jdv.12595

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results.

Authors:  Paulina Kiluk; Anna Baran; Tomasz W Kaminski; Magdalena Maciaszek; Iwona Flisiak
Journal:  Postepy Dermatol Alergol       Date:  2021-02-07       Impact factor: 1.664

2.  Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study.

Authors:  Danijela Milčić; Slavenka Janković; Sonja Vesić; Mirjana Milinković; Jelena Marinković; Andja Ćirković; Janko Janković
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

3.  Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis.

Authors:  Lenka Borska; Jan Kremlacek; Ctirad Andrys; Jan Krejsek; Kvetoslava Hamakova; Pavel Borsky; Vladimir Palicka; Vit Rehacek; Andrea Malkova; Zdenek Fiala
Journal:  Int J Mol Sci       Date:  2017-10-25       Impact factor: 5.923

4.  An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies.

Authors:  Sanminder Singh; Paulina Young; April W Armstrong
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

5.  Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population.

Authors:  Hatice Gül Dursun; Hüseyin Osman Yılmaz; Recep Dursun; Sevsen Kulaksızoğlu
Journal:  J Immunol Res       Date:  2018-04-23       Impact factor: 4.818

Review 6.  Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.

Authors:  Stephen Chu-Sung Hu; Cheng-Che E Lan
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

Review 7.  Association between metabolic syndrome and psoriasis: a meta-analysis of observational studies with non-psoriasis control groups.

Authors:  Ju Qiao; Qian-Nan Jia; Hong-Zhong Jin
Journal:  Arch Med Sci       Date:  2020-01-31       Impact factor: 3.318

8.  Changes in metabolic syndrome and risk of psoriasis: a nationwide population-based study.

Authors:  Hyun Ji Lee; Kyung Do Han; Hae Eun Park; Ju Hee Han; Chul Hwan Bang; Young Min Park; Ji Hyun Lee
Journal:  Sci Rep       Date:  2021-12-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.